New usage paradigms in antibody therapy: Induction or true prophylaxis?

被引：5

作者：

Kirkman, RL ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA USA

来源：

TRANSPLANTATION PROCEEDINGS | 1999年 / 31卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(98)01976-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1234 / 1235

页数：2

共 7 条

[1] PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL-ANTIBODY USED IN CADAVERIC RENAL-TRANSPLANTATION [J].

AMLOT, PL ;

RAWLINGS, E ;

FERNANDO, ON ;

GRIFFIN, PJ ;

HEINRICH, G ;

SCHREIER, MH ;

CASTAIGNE, JP ;

MOORE, R ;

SWENY, P .

TRANSPLANTATION, 1995, 60 (07) :748-756

[2] A RANDOMIZED PROSPECTIVE TRIAL OF ANTI-TAC MONOCLONAL-ANTIBODY IN HUMAN RENAL-TRANSPLANTATION [J].

KIRKMAN, RL ;

SHAPIRO, ME ;

CARPENTER, CB ;

MCKAY, DB ;

MILFORD, EL ;

RAMOS, EL ;

TILNEY, NL ;

WALDMANN, TA ;

ZIMMERMAN, CE ;

STROM, TB .

TRANSPLANTATION, 1991, 51 (01) :107-113

[3] ADMINISTRATION OF AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY PROLONGS CARDIAC ALLOGRAFT SURVIVAL IN MICE [J].

KIRKMAN, RL ;

BARRETT, LV ;

GAULTON, GN ;

KELLEY, VE ;

YTHIER, A ;

STROM, TB .

JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (01) :358-362

[4] Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts [J].

Kovarik, J ;

Wolf, P ;

Cisterne, JM ;

Mourad, G ;

Lebranchu, Y ;

Lang, P ;

Bourbigot, B ;

Cantarovich, D ;

Girault, D ;

Gerbeau, C ;

Schmidt, AG ;

Soulillou, JP .

TRANSPLANTATION, 1997, 64 (12) :1701-1705

[5] Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients [J].

Nashan, B ;

Moore, R ;

Amlot, P ;

Schmidt, AG ;

Abeywickrama, K ;

Soulillou, JP .

LANCET, 1997, 350 (9086) :1193-1198

[6] A HUMANIZED ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR [J].

QUEEN, C ;

SCHNEIDER, WP ;

SELICK, HE ;

PAYNE, PW ;

LANDOLFI, NF ;

DUNCAN, JF ;

AVDALOVIC, NM ;

LEVITT, M ;

JUNGHANS, RP ;

WALDMANN, TA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :10029-10033

[7] Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation [J].

Vincenti, F ;

Kirkman, R ;

Light, S ;

Bumgardner, G ;

Pescovitz, M ;

Halloran, P ;

Neylan, J ;

Wilkinson, A ;

Ekberg, H ;

Gaston, R ;

Backman, L ;

Burdick, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (03) :161-165

← 1 →